Alight ALIT 深 滬
已收盤 08-29 16:00:00 美东时间
3.88
-0.010
-0.26%
華盛通- 最 高4.007
- 今 開3.95
- 成交量 567.92万股
- 最 低 3.85
- 昨 收 3.89
- 總市值 20.53亿
- 52周最高 8.805
- 市盈率 靜 --
- 換手率 1.07%
- 52周最低 3.615
- 委 比 88.52%
- 總股本 5.29亿
- 歷史最高 14.39
- 量 比 0.83
- 振 幅 4.04%
- 歷史最低 3.615
- 每 手 1
- 風險率 1.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Rivian遭多家大行下调目标价；巴克莱上调超微公司目标价从130美元升至200美元
今日重点评级关注：韦德布什：维持Gossamer Bio"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持EyePoint Pharmaceuticals"买入"评级，目标价从22美元升至23美元
08-07 09:46
Needham Maintains Buy on Alight, Lowers Price Target to $6
Needham analyst Kyle Peterson maintains Alight (NYSE:ALIT) with a Buy and lowers the price target from $8 to $6.
08-06 20:13
12 Industrials Stocks Moving In Tuesday's Intraday Session
Gainers SolarMax Technology (NASDAQ:SMXT) stock moved upwards by 80.4% to $1.6...
08-06 01:06
Alight shares are trading higher after the company reported a Q2 sales beat.
Alight shares are trading higher after the company reported a Q2 sales beat.
08-05 20:29
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
Wall Street's Most Accurate Analysts Spotlight On 3 Industrials Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn ...
08-04 20:33
Preview: Trinet Group's Earnings
Trinet Group (NYSE:TNET) will release its quarterly earnings report on Friday, ...
07-24 22:02
California Urban Housing Development Exempted From CEQA: A Game Changer?
California lawmakers have exempted most urban housing development from the California Environmental Quality Act (CEQA).
07-07 01:01
期权扫描 | 英伟达期权成交至337万张！Unity一看涨期权涨超200%
英伟达股价再刷新高，期权成交至337万张；Unity涨超7%，一看涨期权涨超200%；Robinhood与OpenAI合作落空，期权成交回落至77万张>>
07-04 20:10
Achieve Life Sciences Announces Proposed Underwritten Public Offering
Achieve Life Sciences Inc. announced a proposed underwritten public offering of its common stock and warrants. The company plans to use proceeds to advance cytisinicline, a potential smoking cessation treatment, through FDA approval and for general corporate purposes. The offering is subject to market conditions and SEC registration. Cytisinicline has shown promise in Phase 3 studies and seeks to address nicotine dependence, including vaping cess...
06-26 20:03
